INS and Hypertension: On the basis that insulin decreases the production of this strong vasodilator, Parker and coworkers suggested that hypertension associated with insulin resistance and hyperinsulinemia (i.e., metabolic syndrome) would be due partly caused by the lack of proper PGI2 release [69].